ID   UMK-1 [Human bladder carcinoma]
AC   CVCL_WL40
DR   Wikidata; Q98134206
RX   PubMed=7610502;
RX   PubMed=8348978;
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=7610502).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
RX   PubMed=7610502; DOI=10.1159/000282721;
RA   Muraoka, Keisuke
RA   Nabeshima, Kazuki
RA   Kataoka, Hiroaki
RA   Kishi, Junichi
RA   Koono, Masashi
RT   "Establishment of a new human urinary bladder mixed carcinoma cell
RT   line UMK-1 and its cell-density-dependent secretion of gelatinases
RT   and tissue inhibitor of metalloproteinase-1.";
RL   Urol. Int. 54:184-190(1995).
//
RX   PubMed=8348978; DOI=10.1016/0014-5793(93)80946-R;
RA   Kataoka, Hiroaki
RA   Seguchi, Kohji
RA   Inoue, Teruhiko
RA   Koono, Masashi
RT   "Properties of alpha 1-antitrypsin secreted by human adenocarcinoma
RT   cell lines.";
RL   FEBS Lett. 328:291-295(1993).
//